Table 3 Differences in sexual dysfunction between the sample groups
PRSexDQ-SALSEX variables | Methadone (N = 329) | Buprenorphine (N = 264) | p value | ||||||
|---|---|---|---|---|---|---|---|---|---|
None | Mild | Moderate | Severe/extreme | None | Mild | Moderate | Severe/extreme | ||
1. Decrease in desire for sexual activity (%) | 51.5 | 23.8 | 14.6 | 10.1 | 64.2 | 21.9 | 6.4 | 7.5 | 0.002 |
2. Delay in ejaculation/orgasm (%) | 56.4 | 21.3 | 13.4 | 8.8 | 69.8 | 15.8 | 7.9 | 6.4 | 0.008 |
3. Unable to ejaculate/to have an orgasm once you begin sexual relation (%) | 61.6 | 26.2 | 7.6 | 4.6 | 76.6 | 14.3 | 4.5 | 4.5 | 0.001 |
4. Experienced difficulties obtaining an erection/vaginal lubrication once the sexual activity is initiated (%) | 60.4 | 23.8 | 9.5 | 6.4 | 69.4 | 22.1 | 5.3 | 3.0 | 0.032 |
5. Tolerated changes in sexual relations (%) | 39.3 | 31.4 | 23.5 | 5.8 | 53.2 | 31.7 | 12.5 | 2.6 | < 0.001 |